Blocking of MHC class I antigens on leukemic B-cells enhances their conjugate formation with cytotoxic lymphocytes and their susceptibility to lysis

Leukemia and Lymphoma

Volumn 28, Issue 5-6, 1998, Pages 573-581

  Palucka, Karolina A ^a   Reizenstein, Peter ^b   Ost, Ake ^b   Porwit Macdonald, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion molecules; Chronic lymphocytic leukemia; Lymphokine activated killer cells; MHC class I; Natural killer cells

Indexed keywords

CELL ADHESION MOLECULE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL MEDIATED CYTOTOXICITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONJUGATION; CYTOTOXIC LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; IMMUNOCYTOMA; LEUKEMIA CELL; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 0031948949     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809058366     Document Type: Article

References (24)

1. Storkus, W. J. and Davvson, J. R. (1991). Target structures involved in natural killing (NK): characteristics, distribution and candidate molecules. Critical Reviews in Immunology, 10, 393-116.
2. Storkus, W. J., Alexander, J., Payne, J., Dawson, J. R. and Cresswell, P. (1989). Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proceedings of National Academy of Science USA, 86, 2361-2362.
3. Liao, N. S., Bix, M., Zijlstra, M., Jaenisch, R. and Raulet, D. ( 1991 ). MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science, 253, 199-202.
4. Quillet, A., Presse, F., MarchioI-Foumigault, C., Harel-Bellan, A., Benbunan, M., Ploegh, H. and Fradelizi, D. (1988). Increased resistance to non-MHC-restricted cytotoxicity related to HLA A, B expression. Journal of Immunology, 141, 17-20.
5. Quillet-Mary, A., Cavarec, L., Kermarrec, N., MarchiolFournigault, C., Gil, M. L., Conjeaud,- H. and Fradelize, D. (1991). Target lysis by human LAK cells is critically dependent upon target binding properties but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets. International Journal of Cancer, 47,473-479.
6. Shimizu, Y. and DeMars, R. (1989). Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. European Journal of Immunology, 19? 447-151.
7. Dawson, J. R., Wyatt, R. M. and Storkus, W. J. (1992). Natural killer cell-B lymphocyte interactions: the role of target cell major histocompatibility class I molecules. In NK cell mediated cytotoxicity, E. Lotzovâ and R. Herberman, (eds.) pp. 409-422. (CRC Press, Boca Raton, Florida.)
8. Timonen, T., Gahmberg, C. and Patarroyo, M. (1990). Participation of CD1 la-c/CDI8, CD2 and RGD-binding receptors in endogenous and Interelukin-2-stimulated NK activity of CD3-negative large granular lymphocytes. International Journal ofCancer, 46, 1035-1040.
9. Gregory, C., Murray, R., Edwards, C. and Rickinson, A. (1988). Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cells escpae from virus-specific T-cell surveilance. Journal of Experimental Medicine, 167, 1811-1824.
10. Jansen, J., Harst, D., Wientjens, G. J., Kooy-Winkelaar, Y., Brand, A., Willemze, R. and Kluin-Nelemans, H. (1992). Induction of CD 11 a/Leukocyte function antigen-1 and CD54/Intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity. Blood, 80,478-483.
11. Lennert, K., Mohri, N., Stein, H., Kaiserling, E. and MüllerHermelink, E. (1978). Malignant lymplioinas other than Hodgkin's disease, Berlin: Springer Verlag.
12. Carbone, P., Kaplan, H., Muschoff, K., Smithers, D. and Tubiana, M. (1971). Report of the commitee on Hodgkin's disease staging classification. Cancer Research, 31, 1860-1865.
13. Palucka, A. K., Porwit, A. and Reizenstein, P. (1993). Binding of leukemic blasts to various subpopulations of lymphokineactivated killer cells. Scandinavian Journal of Immunology, 37, 179-185.
14. McMichael, A., Parham, P., Brodsky, F. and Pilch, J. (1980). Influenza virus-specific cytotoxic T-lymphocytes recognize HLA molecules. Journal of Experimental Medicine, 152, 195-203.
15. Naganuma, H., Halapi, E., Masucci, G., Hansson, M., Wersäll, P., Hising, C., Venkateswaran, S., Mellsted, H. and Kiessling, R. (1992). Diverse effect of cytokine treatment of tumor cells on specific versus non-specific cytotoxicity. Medical Oncology & Tumor Phartnacotherapy, 9, 25-33.
16. Spertini, F., Chatila, T. and Geha, R. (1992). Engagement of MHC class I molecules induces cell adhesion via both LFA-1 dependent and LFA-1 independent pathways. Journal of Immunology, 148, 2045-2048.
17. Sugawara, S., Abo, T., Itoh, H. and Kumagai, K. (1989). Analysis of mechanisms by which NK cells acquire increased cytotoxicity against class I MHC-eliminated targets. Cellular Immunology, 119,304-316.
18. Dubey, D. P., Alper, C. A., Mirza, N. M., Awdeh, Z. and Yunis, E. J. (1994). Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity. Journal of Experimental Medicine, 179, 1193-1203.
19. Litwin, V., Gumperz, J., Parham, P., Phillips, J. H. and Lanier, L. L. (1994). NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. Journal of Experimental Medicine, 180, 537-543.
20. Kaufman, D. S., Schoon, R. A. and Leibson, P. J. (1993). MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition. Journal of Immunology, 150, 1429-1436.
21. Möller, P., Herrmann, B., Moldenhauer, G. and Momburg, F. (1987). Defective expression of MHC class I antigens is fre-quent in B-cell lymphomas of high-grade malignancy. International Journal of Cancer, 40, 32-39.
22. Öhlen, C. (1992). Role ofMHC class I molecules and antigen presentation in recognition ofallogeneic grafts by T-cells and NK cells. Doctoral Thesis. Stockholm: Karolinska Institute.
23. Smits, K. M., Kuppen, P. J. K., Eggermont, A. M. M. and Fleuren, G. J. (1993). Preincubation of tumor cells with the anti-(MHC) class I antibody OX18 enhances tumor cell lysis by Interleukin-2-activated NK cells. Transplantation Proceedings, 25, 2806-2807.
24. Ljunggren, H. G. and Karre, K. (1990). In search of the missing self: MHC molecules and NK cell recognition. Immunology Today, 11, 237-244.